Journals / Ege Tıp Dergisi / 2021 / Cilt: 60 - Sayı: Supplement

Rational drug use: Warfarin

Akılcı ilaç kullanımı: Varfarin

Pages
19–31
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, it is necessary to know that warfarin metabolism is affected by genetic factors, to recognize side effects, drug and food interactions better, and to emphasize the importance of making fast and accurate decisions when toxicity and complications occur.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Warfarin is the most widely used anticoagulant by physicians in many indications and in many different branches in order to prevent thrombosis in the world.
📊
Key Findings & Data:In addition to having a narrow therapeutic index, it has serious interactions with a large number of medicines and plants.
💡
Conclusion & Impact:Therefore, it is necessary to know that warfarin metabolism is affected by genetic factors, to recognize side effects, drug and food interactions better, and to emphasize the importance of making fast and accurate decisions when toxicity and complications occur.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Warfarin is the most widely used anticoagulant by physicians in many indications and in many different branches in order to prevent thrombosis in the world. In addition to having a narrow therapeutic index, it has serious interactions with a large number of medicines and plants. Although alternative oral anticoagulant agents have recently been developed, there is insufficient evidence that they are effective and safe in rheumatologic diseases such as antiphospholipid antibody syndrome and systemic lupus erythematosus. Therefore, it is necessary to know that warfarin metabolism is affected by genetic factors, to recognize side effects, drug and food interactions better, and to emphasize the importance of making fast and accurate decisions when toxicity and complications occur.

Özet

Varfarin, dünyada trombozun önlenmesi amacıyla çok sayıda endikasyonda ve çok sayıda farklı branşta hekimce en yaygın kullanılan antikoagülandır. Dar bir terapötik indekse sahip olmasının yanı sıra çok sayıda ilaç ve bitki ile ciddi etkileşmeleri de vardır. Her ne kadar yakın zamanda alternatif oral antikoagülan ajanlar geliştirilmiş olsa da bunların antifosfolipid antikor sendromu, sistemik lupus eritematoz gibi romatolojik hastalıklarda etkin ve güvenli olduğuna dair yeterli kanıt yoktur. Bu nedenle varfarin metabolizmasının genetik etkenlerden belirgin etkilendiğini bilmek, yan etkilerini, ilaç ve gıda etkileşmelerini daha iyi tanımak, toksisite ve komplikasyon olduğu zaman hızlı ve doğru karar verebilmenin önemini vurgulamak gerekiyor.

🔖

Cite This Article

Gerdan, V. (2022). Rational drug use: Warfarin. Ege Tıp Dergisi, Cilt: 60 - Sayı: Supplement, 19–31. https://ajindex.com/articles/496088

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. . Pirmohamed M. Warfarin: almost 60 years old and still causing problems. Br J Clin Pharmacol 2006
  2. 62 (5): 509-11. 2. Ramachandran S, Pitchai S. Story of warfarin: From rat poison to lifesaving drug. Indian J Vasc Endovasc Surg 2018
  3. Shapiro SS. Treating thrombosis in the 21st century. N Engl J Med [editorial] 2003
  4. 349 (18): 1762-4. 4. Hirsh J, Dalen J, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001
  5. 119 (1 Suppl): 8S-21S. 5. White PJ. Patient factors that influence warfarin dose response. J Pharm Pract 2010
  6. 23 (3): 194-204. 6. James AH, Britt RP, Raskino CL, et al. Factors affecting the maintenance dose of warfarin. J Clin Pathol 1992
  7. 45 (8): 704-706. 7. Hylek EM. Oral anticoagulants pharmacologic issues for use in elderly. Clin Geriatr Med 2001
  8. 17 (1): 1-13. 8. Singla DA, Morrill GB. Warfarin maintenance dosages in the very elderly. Am J Health Syst Pharm 2005
  9. 62 (10): 1062-6. 9. Siguret V, Gouin I, Debray M, et al. Initiation of warfarin therapy in elderly medical inpatients: A safe and accurate regimen. Am J Med 2005
  10. 118 (2): 137-42. 10.O‟Connell MB, Kowal PR, Allivato CJ, et al. Evaluation of warfarin initiation regimens in elderly inpatients. Pharmacotherapy. 2000
  11. 20 (8): 923-930. 11.Ansell J, Hirsh J, Hylek E, et al. Pharmacology and management of the vitamin K antagonists. Chest 2008
  12. 133(6 suppl): 160S-198S 12.Absher RK, Moore ME, Parker MH. Patient-specific factors predictive of warfarin dosage requirements. Ann Pharmacother 2002
  13. 36 (10): 1512-7. 13.Cushman M, Booth SL, Possidente CL, et al. The association of vitamin K status with warfarin sensitivity at the onset of treatment. Br J Haematol 2001
  14. 112 (3): 572-7. 14.Couris R, Tataronis G, McCloskey W, et al. Dietary vitamin K variability affects international normalized ratio (INR) coagulation indices. Int J Vitam Nutr Res 2006
  15. 76 (2): 65-74. 15.Franco V, Polanczyk CA, Clausell N, et al. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. Am J Med 2004
  16. 116 (10): 651-6. 16.Kurnick D, Loebstein R, Rabinovitz H, Austerweil N, Halkin H, Almog S. Over-the-counter vitamin K1- containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. Thromb Haemost 2004
  17. 92 (5): 1018-24. 17.Sconce E, Avery P, Wynne H, et al. Vitamin K supplementation can improve stability of anticoagulation for